Back to resultsStudy of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
Primary Purpose
Bipolar Disorder
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
aripiprazole
Sponsored by
About this trial
This is an interventional treatment trial for Bipolar Disorder focused on measuring Bipolar I Disorder
Eligibility Criteria
Inclusion Criteria: Patients with acute symptoms of Bipolar Disorder
Sites / Locations
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00036101
First Posted
May 7, 2002
Last Updated
November 7, 2013
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00036101
Brief Title
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
Study Type
Interventional
2. Study Status
Record Verification Date
September 2007
Overall Recruitment Status
Completed
Study Start Date
February 2002 (undefined)
Primary Completion Date
January 2003 (Actual)
Study Completion Date
January 2003 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar Disorder
Keywords
Bipolar I Disorder
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
aripiprazole
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with acute symptoms of Bipolar Disorder
Facility Information:
Facility Name
Local Institution
City
Tuscaloosa
State/Province
Alabama
Country
United States
Facility Name
Local Institution
City
Little Rock
State/Province
Arizona
Country
United States
Facility Name
Local Institution
City
Beachwood
State/Province
California
Country
United States
Facility Name
Local Institution
City
Chula Vista
State/Province
California
Country
United States
Facility Name
Local Institution
City
Riverside
State/Province
California
Country
United States
Facility Name
Local Institution
City
San Clemente
State/Province
California
Country
United States
Facility Name
Local Institution
City
San Diego
State/Province
California
Country
United States
Facility Name
Local Institution
City
Stanford
State/Province
California
Country
United States
Facility Name
Local Institution
City
Washington
State/Province
District of Columbia
Country
United States
Facility Name
Local Institution
City
North Miami
State/Province
Florida
Country
United States
Facility Name
Local Institution
City
Winter Park
State/Province
Florida
Country
United States
Facility Name
Local Institution
City
Honolulu
State/Province
Hawaii
Country
United States
Facility Name
Local Institution
City
Chicago
State/Province
Illinois
Country
United States
Facility Name
Local Institution
City
Indianapolis
State/Province
Indiana
Country
United States
Facility Name
Local Institution
City
Louisville
State/Province
Kentucky
Country
United States
Facility Name
Local Institution
City
Belmont
State/Province
Massachusetts
Country
United States
Facility Name
Local Institution
City
Newton Center
State/Province
Massachusetts
Country
United States
Facility Name
Local Institution
City
New Baltimore
State/Province
Michigan
Country
United States
Facility Name
Local Institution
City
Lawrence
State/Province
New York
Country
United States
Facility Name
Local Institution
City
Butner
State/Province
North Carolina
Country
United States
Facility Name
Local Institution
City
Cincinnati
State/Province
Ohio
Country
United States
Facility Name
Local Institution
City
Medina
State/Province
Ohio
Country
United States
Facility Name
Local Institution
City
Philadelphia
State/Province
Pennsylvania
Country
United States
Facility Name
Local Institution
City
Austin
State/Province
Texas
Country
United States
Facility Name
Local Institution
City
Houston
State/Province
Texas
Country
United States
Facility Name
Local Institution
City
Falls Church
State/Province
Virginia
Country
United States
Facility Name
Local Institution
City
Bellevue
State/Province
Washington
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
We'll reach out to this number within 24 hrs